ישראל - עברית - Ministry of Health

teva medical marketing ltd. - glucose hydrous 5 g / 100 ml; sodium chloride 450 mg / 100 ml - solution for infusion - sodium chloride - source of water electrolytes and calories.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 % - sodium chloride - sodium chloride - a source of water and electrolytes. also indicated for use as priming solutions in hemodialysis procedures.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - gentamicin as sulfate 80 mg / 100 ml - solution for injection - gentamicin - treatment of serious infections caused by susceptible microorganisms.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - magnesium chloride 0.3 mg/ml; potassium chloride 0.37 mg/ml - solution for injection - solutions affecting the electrolyte balance - indicated as a source of water and electrolytes or as an alkalinizing agent.

ישראל - עברית - Ministry of Health

teva medical marketing ltd. - glucose hydrous 50 mg/ml; sodium chloride 9 mg/ml - solution for infusion - solutions for parenteral nutrition - source of water, electrolytes and calories.

ישראל - עברית - Ministry of Health

takeda israel ltd - factor viii inhibitor bypassing fraction - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - factor viii inhibitor bypassing fraction 500 u/vial - factor viii inhibitor bypassing activity - factor viii inhibitor bypassing activity - for the control of bleeding episodes in haemophilia a patients with factor viii inhibitors and also in patients with acquired factor viii inhibitors.

ישראל - עברית - Ministry of Health

remedix care ltd - olive oil; soya oil - תחליב לאינפוזיה - olive oil 80 %; soya oil 20 % - oil - oil - source of lipids during parenteral nutrition in situations where oral or enteral feeding is impossible, insufficient or contra-indicated.